Free Trial
OTCMKTS:BCTXF

BriaCell Therapeutics (BCTXF) Stock Price, News & Analysis

BriaCell Therapeutics logo
$0.60 -0.05 (-7.69%)
(As of 11/13/2024 ET)

About BriaCell Therapeutics Stock (OTCMKTS:BCTXF)

Key Stats

Today's Range
$0.57
$0.66
50-Day Range
$0.47
$1.24
52-Week Range
$3.25
$17.50
Volume
647,295 shs
Average Volume
1,859 shs
Market Capitalization
$463,508.80
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

Receive BCTXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

BCTXF Stock News Headlines

BriaCell Unveils Promising Cancer Therapy Data
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
BriaCell falls on $5M stock offering
See More Headlines

BCTXF Stock Analysis - Frequently Asked Questions

BriaCell Therapeutics' stock was trading at $5.85 on January 1st, 2024. Since then, BCTXF stock has decreased by 89.7% and is now trading at $0.6004.
View the best growth stocks for 2024 here
.

Shares of BCTXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:BCTXF
CIK
N/A
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Net Income
$-3,680,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($4.55) per share

Miscellaneous

Free Float
N/A
Market Cap
$501,800.00
Optionable
Not Optionable
Beta
1.09
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (OTCMKTS:BCTXF) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners